Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: PDB22 Implications for Access to Insulin and Biosimilars: A Survey on Insulin Prices, Availability and Affordability in the Philippines, Value in Health, June 2021, Elsevier,
DOI: 10.1016/j.jval.2021.04.420.
You can read the full text:

Read

Contributors

The following have contributed to this page